Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase versus tenecteplase in acute ischemic stroke (registry-based pragmatic RCT)
2020-001982-36Phase 3Terminated
- Sponsor
- St. Anne's University Hospital Brno
- Start
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of tenecteplase in ischemic stroke (2 arms), sponsored by St. Anne's University Hospital Brno. Primary endpoint: Functional independence at 90–120 days. Started Jul 2020; status: terminated.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on 2020-001982-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001982-36.